Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2209 ARTÍCULOS , VIENDO DEL 556 AL 570

Robust automated detection of microstructural white matter degeneration in Alzheimer's disease using machine learning classification of multicenter DTI data

Dyrba M, Ewers M, Wegrzyn M, Kilimann I, Plant C, Oswald A, Meindl T, Pievani M, Bokde AL, Fellgiebel A, Filippi M, Hampel H, Klöppel S, Hauenstein K, Kirste T, Teipel SJ; EDSD study group.

PLoS One. 2013 May 31;8(5):e64925. doi: 10.1371/journal.pone.0064925. Print 2013.

Intraneuronal tau aggregation precedes diffuse plaque deposition, but amyloid-β changes occur before increases of tau in cerebrospinal fluid

Braak H, Zetterberg H, Del Tredici K, Blennow K.

Acta Neuropathol. 2013 Nov;126(5):631-41. doi: 10.1007/s00401-013-1139-0. Epub 2013 Jun 12.

Model-based quantification of cerebral hemodynamics as a physiomarker for Alzheimer's disease?

Marmarelis VZ, Shin DC, Orme ME, Zhang R.

Ann Biomed Eng. 2013 Nov;41(11):2296-317. doi: 10.1007/s10439-013-0837-z. Epub 2013 Jun 15.

The neurobiology of aging and Alzheimer's disease: walking down the same road?

Jannic B, Karl F, Nicole L, Richard R.

Eur J Neurosci. 2013 Jun;37(12):1885-6. doi: 10.1111/ejn.12261.

Cerebrovascular contributions to Alzheimer's disease pathophysiology and potential therapeutic interventions in mouse models

Thomason LA, Stefanovic B, McLaurin J.

Eur J Neurosci. 2013 Jun;37(12):1994-2004. doi: 10.1111/ejn.12181.

CASP3 and LDOC-1 gene expression in a patient with carcinoma in the hairy part of the head skin and Alzheimer disease

Salemi M, Soma PF, Bosco P, Vicari E, Castiglione R, Calogero AE.

Hum Cell. 2013 Sep;26(3):128-30. doi: 10.1007/s13577-012-0052-5. Epub 2013 Jun 18.

CYP46A1 intron-2T/C polymorphism and Alzheimer's disease: an updated meta-analysis of 16 studies including 3,960 cases and 3,828 controls

Li M, Wang W, Li Y, Wang L, Shen X, Tang Z.

Neurosci Lett. 2013 Aug 9;549:18-23. doi: 10.1016/j.neulet.2013.06.011. Epub 2013 Jun 17.

[Pathogenesis of the basal forebrain cholinergic dysfunction in Alzheimer's disease]

Mukhin VN.

Ross Fiziol Zh Im I M Sechenova. 2013 Jul;99(7):793-804.

Meta-analysis of the association between urokinase-plasminogen activator gene rs2227564 polymorphism and Alzheimer's disease

Wu W, Jiang H, Wang M, Zhang D.

Am J Alzheimers Dis Other Demen. 2013 Aug;28(5):517-23. doi: 10.1177/1533317513494450. Epub 2013 Jun 28.

Oxidative stress and amyloid beta toxicity in Alzheimer's disease: intervention in a complex relationship by antioxidants

Chakrabarti S, Sinha M, Thakurta IG, Banerjee P, Chattopadhyay M.

Curr Med Chem. 2013;20(37):4648-64. doi: 10.2174/09298673113209990152.

Deconstructing mitochondrial dysfunction in Alzheimer disease

García-Escudero V, Martín-Maestro P, Perry G, Avila J.

Oxid Med Cell Longev. 2013;2013:162152. doi: 10.1155/2013/162152. Epub 2013 Jun 11.

Oxidative stress in Alzheimer's disease: Primary villain or physiological by-product?

Sutherland GT, Chami B, Youssef P, Witting PK.

Redox Rep. 2013;18(4):134-41. doi: 10.1179/1351000213Y.0000000052.

Mitochondrial DNA deletions in Alzheimer's brains: a review

Phillips NR, Simpkins JW, Roby RK.

Alzheimers Dement. 2014 May;10(3):393-400. doi: 10.1016/j.jalz.2013.04.508. Epub 2013 Jul 11.

Cholinergic circuitry of the human nucleus basalis and its fate in Alzheimer's disease

Mesulam MM.

J Comp Neurol. 2013 Dec 15;521(18):4124-44. doi: 10.1002/cne.23415.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias